InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,515.60
(
0.09%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
74.97
(
1.20%
)
Bitcoin
68,752.35
(
0.02%
)
Post# of 473077
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Jonjones325

Send PM Follow Ignore
Followers 34
Posts 3036
Boards Moderated 0
Alias Born 02/27/2016

Jonjones325

Re: None

Wednesday, 06/12/2024 11:39:45 AM

Wednesday, June 12, 2024 11:39:45 AM

Post# of 473077
Are there any arguments against approving Blarcasamine besides for?
-trial may be too small and may be a little too short
-it was only a 2b/3 after a very tiny 2a

Seems that the arguments for approval vastly outweigh. The above can be answered with a confirmation trial after full approval. OLE can put some of that to bed as well.

Also for those that are more knowledgeable, it is my understanding that OLE data can be complied and gathered as patients finish making it a much faster process. Also, other measurements aside from the Adas and CDR can wait as they are less important at this time in terms of confirmation. If Adas and CDR are not what is expected, then the other OLE data will rise in importance and take much longer to flush out.

Either way, it is also my understanding that MAA is moving forward without waiting for any OLE data.

Thoughts?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!